Heart failure & cardiomyopathiesMeta-analysis

Mitral regurgitation and all-cause mortality in acute heart failure; a meta-analysis

ESC Heart FailPublished

  • meta-analysis

Authors' conclusion

We observed that MR during AHF is associated with increased mortality. Although causality cannot be inferred due to the observational design and high heterogeneity of the included studies, MR may represent a phenotype amenable to targeted therapies during decompensated heart failure.

Study context

Population
Acute heart failure (AHF) patients with mitral regurgitation (MR)27 studies, age 72.9±4.2years, females 44.4%, average follow-up of 1.9 years
Participants
73,363 patients
Comparison
Moderate/severe MR compared to no/mild MR

Pooled result

All-cause mortality (unadjusted) · average follow-up of 1.9 years

Odds ratio

1.47

95% CI 1.30–1.66

P < 0.001

Moderate/severe MR vs no/mild MR
OR 1.47 (95% CI 1.30–1.66); P < 0.001

As reported in the abstract

Further pooled results

OutcomeOR (95% CI)P value
All-cause mortality (studies reporting adjusted data) · adjusted data1.21 (1.01–1.45)P = 0.038
All-cause mortality by MR severity — mild MR vs no MR1.22 (0.98–1.53)P = 0.079
All-cause mortality by MR severity — moderate MR vs no MR1.48 (1.1–2.01)P = 0.011
All-cause mortality by MR severity — severe MR vs no MR1.60 (1.13–2.27)P = 0.008
All-cause mortality by LVEF (subgroup) — Moderate/severe MR vs no/mild MR · LVEF <50%1.26 (1.18–1.35)P < 0.001
All-cause mortality by LVEF (subgroup) — Moderate/severe MR vs no/mild MR · LVEF 40-50%2.00 (1.59–2.50)P < 0.001
All-cause mortality by LVEF (subgroup) — Moderate/severe MR vs no/mild MR · LVEF >50%1.16 (0.91–1.47)P = 0.23

Meta-regression and sensitivity analyses

Neither meta-regression nor pre-specified sensitivity analyses affected MR’s association with the primary outcome
A substantial degree of heterogeneity was observed across the included studies

Original publication

Mitral regurgitation and all-cause mortality in acute heart failure; a meta-analysis. ESC Heart Fail. Published 4 August 2026. doi:10.1093/eschf/xvag200

Summarised from the published abstract; every number is checked against it